Cours Acasti Pharma Inc Toronto S.E.
Actions
APO
CA00430K4028
Produits pharmaceutiques
CA 2024 * | - | CA 2025 * | - | Capitalisation | 35,5 M 25,94 M 23,52 M |
---|---|---|---|---|---|
Résultat net 2024 * | -18 M -13,15 M -11,93 M | Résultat net 2025 * | -23 M -16,81 M -15,24 M | VE / CA 2024 * | - |
Trésorerie nette 2024 * | - 0 0 | Trésorerie nette 2025 * | - 0 0 | VE / CA 2025 * | - |
PER 2024 * |
-1,95
x | PER 2025 * |
-2,51
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 83,98% |
Dernier transcript sur Acasti Pharma Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Prashant Kohli
CEO | Chief Executive Officer | 52 | 01/08/21 |
Director of Finance/CFO | 52 | 05/01 | |
Carrie D'Andrea
CTO | Chief Tech/Sci/R&D Officer | 52 | 08/05/23 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
A. Davis
BRD | Director/Board Member | 57 | 10/10/23 |
Director/Board Member | - | 10/10/23 | |
Santosh Kottayil
BRD | Director/Board Member | - | 10/10/23 |
Varia. 1 janv. | Capi. | |
---|---|---|
+32,36% | 695 Md | |
+26,51% | 568 Md | |
-4,40% | 361 Md | |
+19,46% | 330 Md | |
+3,50% | 283 Md | |
+16,47% | 239 Md | |
+7,93% | 204 Md | |
-7,81% | 198 Md | |
+8,62% | 168 Md |